- Home
- HIO vs KMDA Comparison
HIO vs KMDA Comparison
Compare HIO & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIO
- KMDA
- Stock Information
- Founded
- HIO 1993
- KMDA 1990
- Country
- HIO United States
- KMDA Israel
- Employees
- HIO N/A
- KMDA 374
- Industry
- HIO Finance/Investors Services
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- HIO Finance
- KMDA Health Care
- Exchange
- HIO Nasdaq
- KMDA Nasdaq
- Market Cap
- HIO 371.4M
- KMDA 361.1M
- IPO Year
- HIO N/A
- KMDA N/A
- Fundamental
- Price
- HIO $3.60
- KMDA $5.92
- Analyst Decision
- HIO
- KMDA Strong Buy
- Analyst Count
- HIO 0
- KMDA 3
- Target Price
- HIO N/A
- KMDA $14.67
- AVG Volume (30 Days)
- HIO 305.3K
- KMDA 127.2K
- Earning Date
- HIO 01-01-0001
- KMDA 03-05-2025
- Dividend Yield
- HIO 10.33%
- KMDA 3.15%
- EPS Growth
- HIO N/A
- KMDA 66.67
- EPS
- HIO N/A
- KMDA 0.25
- Revenue
- HIO N/A
- KMDA $160,953,000.00
- Revenue This Year
- HIO N/A
- KMDA $11.45
- Revenue Next Year
- HIO N/A
- KMDA $9.94
- P/E Ratio
- HIO N/A
- KMDA $25.54
- Revenue Growth
- HIO N/A
- KMDA 12.93
- 52 Week Low
- HIO $3.52
- KMDA $4.74
- 52 Week High
- HIO $4.03
- KMDA $9.15
- Technical
- Relative Strength Index (RSI)
- HIO 19.96
- KMDA 30.32
- Support Level
- HIO $4.03
- KMDA $6.44
- Resistance Level
- HIO $4.04
- KMDA $6.81
- Average True Range (ATR)
- HIO 0.05
- KMDA 0.23
- MACD
- HIO -0.03
- KMDA -0.07
- Stochastic Oscillator
- HIO 6.58
- KMDA 12.04
About HIO Western Asset High Income Opportunity Fund Inc.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.